Year : 2018 | Volume
: 29 | Issue : 5 | Page : 215-
Overactive bladder: Shortage of good medicine and potential role of traditional Chinese medicine
Stephen Shei-Dei Yang
Department of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi University, Hualien City, Taiwan
Stephen Shei-Dei Yang
Department of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi University, Hualien City
|How to cite this article:|
Yang SS. Overactive bladder: Shortage of good medicine and potential role of traditional Chinese medicine.Urol Sci 2018;29:215-215
|How to cite this URL:|
Yang SS. Overactive bladder: Shortage of good medicine and potential role of traditional Chinese medicine. Urol Sci [serial online] 2018 [cited 2019 Dec 15 ];29:215-215
Available from: http://www.e-urol-sci.com/text.asp?2018/29/5/215/240361
In this issue of Urological Science, Liu and Lee made a good review on “Traditional Chinese Medicine and Herbal Supplements for Treating Overactive Bladder.” It highlights the methodology in evaluating these traditional medicines used long in Chinese history. This review is important in that current modern medicine such as antimuscarinics has a low persistence and high switch rate in treating OAB (Chen et al.). Wisdom of Chinese medicine should be proved by modern methodology evaluating its effectiveness and adverse effects. Hopefully, an effective type of Chinese medicine could be applied to patients with OAB.
Using a database in the National Health Insurance, Huang et al. reported that patients with lower urinary tract symptom (LUTS) had a 1.74 times higher risk of venous thromboembolism which is related to atherosclerosis. Although many urologists believe that venous thromboembolism is rare in Taiwan, this report reminds us that patients with LUTS were at risks of thromboembolism. The prevention of such complications in patients undergoing transurethral resection of the prostate should be carefully investigated in Taiwan. Survival after treatment of pelvic malignancy is more and more common. Liu CS reported a high prevalence of LUTS among these survivals. This information is important for urologists dealing with pelvic organ malignancies.
More issues about the controversy in “Gonadectomy in Patients with Disorder of Sexual Development” and “The Role of Body Mass Index Predicting Outcome of Percutaneous Nephrolithotomy” are reported in this issue.